Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report

Katsuhisa Sekido, Shuichi Imaue*, Kei Tomihara, Hidetake Tachinami, Kentaro Yamagishi, Seisuke Okazawa, Atsushi Ikeda, Kumiko Fujiwara, Makoto Noguchi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.

Original languageEnglish
Article numbere04545
JournalClinical Case Reports
Volume9
Issue number9
DOIs
StatePublished - 2021/09

Keywords

  • anti-PD-1
  • complete remission
  • immune checkpoint inhibitor
  • lung metastasis
  • nivolumab
  • oral squamous cell carcinoma

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report'. Together they form a unique fingerprint.

Cite this